At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the ...

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on changes announced to the US childhood vaccine schedule.

BIO’s Coffee Chat focused on why we need PPRV reauthorization. Plus, a year-end readers’ survey. (821 words, 4 minutes, 6 seconds) Bio.News will take a holiday break. The next newsletter is scheduled ...

Feedback from our readership ensures that Bio.News continues to deliver trusted weekly industry coverage at the intersection of biotech innovation and policy. As a valued subscriber, we thank you for ...

The contents of the member listings on the BIO Web site may not be reproduced or used in any form without prior written permission from BIO. For more information about members, please refer to the ...

BIO is proud to welcome the following innovators to our membership in 2025. Your leadership and engagement strengthens our collective ability to advance policy, drive innovation, and support the next ...

The House passes pro-investment legislation backed by BIO. Plus, Bayh-Dole turns 45. (861 words, 4 minutes, 18 seconds) House passes INVEST Act, BIO-backed legislation to increase access to capital ...